Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Websitecovagen.com
CategoryBioTech
Phone41(0)44 635 60 33
Employees
Founded1/2007
DescriptionProtein Therapeutics

Offices

Zürich, CHE
Y17 M22, Life Science ETH/Uni
Winterthurerstrasse 190
Zürich, 8057, CHE

People

Board of Directors
Board of Directors
Non-Executive Director
Board Positions

Funding

Tags

Covagen

Covagen AG develops protein-based therapeutics for the treatment of inflammatory diseases and cancer. Its products enable the isolation of high affinity protein-based binders called Fynomers, which changes the activity of target molecules relevant in various diseases. Covagen AG was founded in 2007 and is based in Zürich, Switzerland.

Recent Milestones

  • Dollar
    Covagen received $2.81M in Series B funding. (2/20/14)
    Posted 2/20/14 at 4:19am via finsmes.com
  • Dollar
    Covagen received $47.2M in Series B funding. (12/9/13)
    Posted 12/9/13 at 8:37pm via pehub.com
  • Dollar
    Covagen received $6.3M in Series A funding. (11/29/10)
    Posted 11/29/10 at 7:26pm via covagen.com
  • Dollar
    Covagen received $34.2M in Series A funding. (12/1/09)
    Posted 12/1/09 at 11:59am via dowjones.com
  • Dollar
    Covagen received in Seed funding. (10/5/09)
    Posted 12/1/09 at 11:59am via covagen.com

Videos

Screenshots

Covagen screenshot
Above: Home Page
Uploaded: 1/12/10

Sources

  1. Covagen (covagen.com) [edit]
  2. Covagen Extends Seed Funds, Plans For $34M Series A (fis.dowjones.com) [edit]
  3. Covagen closes Series A financing round with Seroba Kernel as lead investor (covagen.com) [edit]
  4. Gimv leads Series B round for Covagen (pehub.com) [edit]
  5. Covagen Raises Additional CHF2.5M in Series B Round (finsmes.com) [edit]
Edit This Page
Last Edited 2/20/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy